Professor Fabienne Mackay
leads a research team dedicated to the development of new therapies to treat lupus.
Professor Mackay's work has been instrumental in the development of a
new treatment called belimumab. This is the first new treatment for
lupus in over 50 years. While this is an advance in medicine it is only
effective in a subset of patients. There is still a large number of
patients awaiting an effective treatment. The team includes Dr Fabien Vincent, a rheumatologist whose research is aimed at understanding why lupus develops differently in different groups of people.